Business · 14/02/2020Updated: 10/17/2026 · 1 min read
FDA Withdraws Approval of 28 Abbreviated New Drug Applications from Multiple Applicants
Summary
The US Food and Drug Administration (FDA) has withdrawn the approval of 28 abbreviated new drug applications (ANDAs) from multiple applicants, following a request from the applicants to discontinue marketing of the drug products.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →